scholarly article | Q13442814 |
P356 | DOI | 10.7326/0003-4819-106-4-524 |
P698 | PubMed publication ID | 3103510 |
P50 | author | Michelle A. Petri | Q67485110 |
P2093 | author name string | Corash L | |
Hellmann D | |||
Whiting-O'Keefe Q | |||
Rheinschmidt M | |||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | systemic lupus erythematosus | Q1485 |
antibody | Q79460 | ||
anticoagulant | Q215118 | ||
patient | Q181600 | ||
anticoagulation | Q63279445 | ||
partial thromboplastin time | Q1755136 | ||
venom | Q3386847 | ||
P304 | page(s) | 524-531 | |
P577 | publication date | 1987-04-01 | |
P1433 | published in | Annals of Internal Medicine | Q564416 |
P1476 | title | The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level | |
P478 | volume | 106 |
Q37131283 | 2013 update: Hopkins lupus cohort |
Q33487561 | A family study of anticardiolipin antibodies and associated clinical conditions |
Q93515633 | Acquired functional protein S deficiency, cerebral venous thrombosis, and coumarin skin necrosis in association with antiphospholipid syndrome: report of two cases |
Q33416443 | Anti-phospholipid antibody with recurrent venous thromboembolism and severe autoimmune thrombocytopenia |
Q33423945 | Anticardiolipin antibodies in patients with autoimmune diseases: isotype distribution and clinical associations |
Q59413161 | Anticorps antiphospholipides au cours du syndrome HELLP : étude clinique et biologique à partir de 68 patientes |
Q34061131 | Antinuclear antibody profiles in relation to specific disease manifestations of systemic lupus erythematosus |
Q94940476 | Antiphospholipid Syndrome |
Q33416855 | Antiphospholipid antibodies and recurrent pregnancy loss |
Q73086663 | Antiphospholipid antibodies and the antiphospholipid antibody syndrome |
Q33498510 | Antiphospholipid antibodies in pediatric lupus nephritis |
Q37063656 | Assessment of the independent associations of IgG, IgM and IgA isotypes of anticardiolipin with thrombosis in SLE. |
Q85206714 | Association of IgA Anti-ß2 Glycoprotein I with Clinical and Laboratory Manifestations of Systemic Lupus Erythematosus |
Q40893344 | Autoimmunity in depression: increased antiphospholipid autoantibodies |
Q35189299 | Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report |
Q33562091 | Cerebrovascular accident and myocardial infarction associated with anticardiolipin antibodies in a young woman with systemic lupus erythematosus |
Q36734776 | Characteristics of patients with systemic lupus erythematosus (SLE) and non-Hodgkin's lymphoma (NHL). |
Q42208790 | Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant: absence of thrombosis |
Q33448275 | Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus |
Q33447381 | Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients |
Q35181703 | Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic disease |
Q33915430 | Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort |
Q31166031 | Diagnosis and pathogenesis of CNS lupus |
Q45191182 | Diagnosis of the antiphospholipid syndrome in anticoagulated patients |
Q34675389 | Evaluation and treatment of vasculitis in the critically ill patient |
Q68098882 | False positive ELISA tests for anticardiolipin antibodies in sera from patients with repeated abortion, rheumatologic disorders and primary biliary cirrhosis: correlation with elevated polyclonal IgM and implications for patients with repeated abort |
Q44460505 | Glomerulonephritis in a patient with anticardiolipin antibody |
Q37161550 | High-sensitivity C-reactive protein as an associate of clinical subsets and organ damage in systemic lupus erythematosus |
Q73683618 | Hopkins Lupus Cohort. 1999 update |
Q33379907 | Immunology and Clinical Importance of Antiphospholipid Antibodies |
Q35632379 | Incidence of anticardiolipin antibodies and lupus anticoagulant factor among women experiencing unexplained recurrent abortion and intrauterine fetal death |
Q47796229 | Incidence of arteriovenous thrombosis and the role of anticardiolipin antibodies in hemodialysis patients |
Q40834203 | Inflammatory ulcers |
Q37823869 | Influence of the lupus anticoagulant on clotting tests |
Q33392824 | Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients |
Q61943926 | LUPUS ANTICOAGULANTS AND ANTIPHOSPHOLIPID ANTIBODIES |
Q40603707 | Laboratory assessment of circulating anticoagulants. |
Q33427841 | Laboratory evaluation of a bleeding patient |
Q33502380 | Localization of the apoptosis-inducing activity of lupus anticoagulant in an annexin V-binding antibody subset |
Q67471070 | Lupus anticoagulant antibodies inhibit collagen-induced adhesion and aggregation of human plateletsin vitro |
Q33393751 | Lupus anticoagulants in systemic lupus erythematosus: prevalence and clinical associations |
Q36373318 | Lupus in Baltimore: evidence-based 'clinical pearls' from the Hopkins Lupus Cohort |
Q33492652 | Lupus-type "anticoagulant" in a dog with hemolysis and thrombosis |
Q37111561 | Methods for detecting lupus anticoagulants and their relation to thrombosis and miscarriage in patients with systemic lupus erythematosus |
Q35535848 | Obstetrical implications of antiphospholipid antibodies |
Q33561285 | Outcome of pregnancy in patients with autoimmune rheumatic disease before the disease onset |
Q33498327 | Pathogenesis and treatment of the antiphospholipid antibody syndrome |
Q28186234 | Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein |
Q51578946 | Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. |
Q33376853 | Prevalence and clinical associations of anticardiolipin antibodies in systemic lupus erythematosus: a prospective study |
Q57316999 | Prevalence and clinical significance of anticardiolipin antibodies in pregnancies complicated by parvovirus B19 infection |
Q33350168 | Prevalence of anticardiolipin antibodies in subacute cutaneous lupus erythematosus |
Q72355315 | Prevalence of antiphospholipid antibodies in nephropathies not due to systemic lupus erythematosus |
Q86527461 | Prevention of recurrent stroke in patients with systemic lupus erythematosus or lupus anticoagulant |
Q40815362 | Primary antiphospholipid antibody syndrome and cerebral ischemia: report on acute intervention in two cases and literature review with emphasis on therapeutic options |
Q38325716 | Pulmonary hypertension in antiphospholipid syndrome |
Q38075430 | Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis |
Q51859166 | Pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome. |
Q41413515 | Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus. |
Q33567589 | Risk factors in the pregnancy of patients with systemic lupus erythematosus: association of hypocomplementaemia with poor prognosis |
Q36709328 | Semiquantified noncalcified coronary plaque in systemic lupus erythematosus |
Q33373583 | Significance of anti-phospholipid antibodies in patients with lupus nephritis |
Q33494866 | Splenic infarction associated with anticardiolipin antibodies in a patient with acquired immunodeficiency syndrome |
Q38844621 | Stroke in systemic lupus erythematosus and antiphospholipid syndrome: risk factors, clinical manifestations, neuroimaging, and treatment |
Q33559469 | Superior mesenteric artery thrombosis associated with antiphospholipid syndrome. |
Q38028943 | Systemic lupus erythematosus and the maternal-fetal dyad |
Q46443879 | Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients |
Q28344247 | Systemic lupus erythematosus presenting earlier as retinal vaso-occlusion |
Q58004012 | Testing strategies for diagnosing lupus anticoagulant: Decision analysis |
Q33393937 | The 'antiphospholipid syndrome' and the 'lupus anticoagulant'. |
Q35167259 | The Hopkins Lupus Pregnancy Center: 1987–1991 Update |
Q34519511 | The lung in the antiphospholipid syndrome |
Q67918343 | The prevalence of autoantibodies during third-trimester pregnancy complicated by hypertension or idiopathic fetal growth retardation |
Q35656148 | The pulmonary physician and critical care. 5. Management of pulmonary embolism |
Q49137186 | The testosterone hypothesis: Assessment since Geschwind and Behan, 1982. |
Q33371184 | The ‘Primary’ Antiphospholipid Syndrome: Antiphospholipid Antibody Pattern and Clinical Features of a Series of 23 Patients |
Q41475203 | Thrombotic syndromes and autoimmune diseases |
Q38149851 | Transient ischemic attack and stroke in systemic lupus erythematosus |
Q36709341 | Utility of antiphosphatidylserine/prothrombin and IgA antiphospholipid assays in systemic lupus erythematosus |
Q44583525 | Vaso-occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy). |
Q48619504 | Visual scotomata resulting from lupus anticoagulant in a patient with lymphoma in remission |
Q68013021 | Visual scotomata resulting from lupus anticoagulant in a patient with lymphoma in remission |
Q67823941 | [Pleuropulmonary manifestations of systemic lupus erythematosus] |
Q77541312 | [The lung in antiphospholipid syndrome] |
Search more.